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1 Introduction  
Loss of neurons and oligodendrocytes in the brain and/or spinal cord induces 
progressive dysfunction of the central nervous system (CNS), leading to neurological 
diseases, such as Parkinson’s disease, Alzheimer’s disease (AD), Huntington disease, 
amyotrophic lateral sclerosis, and multiple sclerosis (MS). Finding effective therapies 
for treatment of these diseases are big challenge in the field of human medicine. 
Recently, stem cell-based cellular therapy for neurodegenerative disease has been 
focused (Fig. 1) and translation medicine develops quickly by transferring new 
techniques from bench to clinic. Therefore, the understanding of signaling pathways 
in differentiating neural stem cell is of great interest (Lunn et al., 2011).  
 
Figure 1. Overview of stem cell technology and stem cell-based cellular therapies.  
The cellular therapy is involved in the treatment of diseases using cells or tissue grafts. Different types 
of stem cells may be utilized and each possesses exclusive characteristic and advantages depending on 
desired outcomes. Selection of proper stem cells for the treatment of neurodegenerative diseases is 
essential for cellular therapies from bench to bedside. Here solid arrows represent divisions within the 
each category and the dashed the source of NPCs and iPS cells. 
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1.1 Stem Cells and Neurogenesis 
Stem cells have two important characteristic features: self-renewal and ability to 
differentiate into different types of cells. Stem cells are essential for maintenance of 
body function by supplying new cells to replace the lost cells induced by normal 
homeostasis or aging, e.g., thousand million new blood cells are produced by the bone 
marrow every day in humans. In different tissues and developmental stages, stem 
cells vary in numbers and types. Based on the ability to develop into other types of 
cells, stem cells are classified into different types: totipotent, pluripotent, and 
multipotent types (Fig. 2). Totipotent stem cells are the one developing from a zygote 
into a 16-cell stage, which have the greatest differentiating potential to develop into 
any one of the three germ layers plus placental cells, giving rise to a functional 
organism. Pluripotent stem cells, also called as embryonic stem cells (ESCs), are 
separated from the inner cell mass of the blastocyst, which can continue to develop 
into any types of cells excluding placenta. The multipotent stem cells can develop into 
more than one cell type, which are limited than pluripotent cells, e.g., neural 
progenitor cells (NPCs) or adult stem cells. All types of these cells can be cultivated 
and grown by in vitro system. 
 
 
Figure 2. Stem cells and cell potency.  
The cells from the morula stage are totipotent and have the ability to become all tissues and placenta. 
The embryonic stem cells originated from the inner cell mass of the blastocyst are pluripotent and can 
form any tissue, excluding placenta in the body. 
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After the three germ layers are established, cells in some part of the ectoderm 
develop into the neural ectoderm, which forms the neural tube. The rostral part of the 
neural tube develops into the brain, including the telencephalon, diencephalon, 
midbrain, cerebellum and hindbrain; while the caudal part into the spinal cord (Fig. 
3). NPCs in the neural tube are multipotent and undergo asymmetric divisions, 
producing neurons, astrocytes, and oligodendrocytes. Recently, adult stem cells have 
also been recognized and identified in the specific regions of the subventricular zone 
in the cortex and the dentate gyrus in the hippocampus (Fig. 3; Temple and Alvarez-
Byulla, 1999; Temple, 2001).  
 
 
Figure 3. The developmental and adult CNS. 
Schematic pictures show embryonic developmental (left) and adult (right) CNS. The different parts of 
the CNS are indicated. The location of adult stem cells can be isolated from the subventricular zone 
(SVZ) (Figure adapted from Temple, 2001). 
  
 
1.2 Stem Cell-Based Therapy  
Replacing lost cells via transplantation with a specific type of stem cells is considered 
as an efficient treatment for various neurodegenerative diseases, such as Parkinson’s 
disease, Alzheimer’s disease, and multiple sclerosis. For example, millions of people 
are affected by Parkinson’s and Alzheimer’s diseases, but no efficient treatment can 
cure patients, although the symptoms can be improved by drug and other methods. 
However, in the animal model, Parkinson’s disease has been almost successfully 
treated using transplantation of human and mouse embryonic stem cells. Dopamine 
producing neurons from hESCs efficiently engraft into mice and rat, and trails are 
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going on with monkeys for the further confirmation (Kriks et al., 2011). Furthermore, 
transplantation with adipose derived stem cells (ADSCs) in the mouse model also 
improves the memory and learning ability, providing a basic knowledge and potential 
platform for treatment of the patients with Alzheimer’s disease (Kim et al., 2012).  
In recent years, research in the field of the stem cell therapy develops quickly 
and the stem cell-based therapies are substantial (Nikolic et al., 2009). Clinical trials 
are on the way for the use of stem cells, especially with autologous transplants, 
although the therapeutic benefit for patients is still in discussion (Trounson et al., 
2011).   
 
1.3 The Wnt Signaling 
The ‘‘Wnt’’ is derived from the abbreviation of two genes - Wg (wingless gene from 
Drosophila) and Int-1 (integration site-1 gene; Nusse and Varmus, 1982). Members of 
the Wnt family are secreted lipid-modified glycoproteins, which have been found in 
all animal species and play key roles in various intracellular processes, such as 
proliferation, differentiation, and cell apoptosis in physiological processes during 
embryonic development. The dysregulation of the Wnt signaling during 
developmental processes induces various diseases, e.g., cancer, type II diabetes 
(Grant, 2006), and osteogenesis imprefecta (Fahiminiya et al., 2013).    
The activation of the Wnt signaling pathway is triggered through the binding 
of the Wnt ligand to its receptor, such as the Frizzled (Fz) receptor - a seven pass 
trans-membrane domains protein - and the co-receptor low-density receptor-related 
protein 5/6 (Lrp5/6) (Fig. 4; Bhanot et al., 1996). According to the receptors and their 
activated effects, Wnt signals are mainly divided into two different pathways: 
 
1. Canonical or the Wnt/β-catenin dependent pathway 
2. Non-canonical or the Wnt/β-catenin independent pathway, including the Wnt/ 
Ca
2+
 dependent pathway and the planar cell polarity (PCP) pathway. 
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Figure 4. Schematic representation of Wnt signalings.  
(A): In the canonical Wnt pathway, the binding of Wnt ligand to its Frizzled (Fz) and Lrp5/6 receptor 
complex induces the stabilization of -catenin through activated dishevelled and -catenin degradation 
complex (GSK3, Axin and casein kinase 1). The stabilized -catenin is translocated into the nucleus, 
where β-catenin forms a complex with TCF/LEF, inducing the target gene expression. -catenin 
exported from nucleus is degraded through the proteasome pathway. (B): In the Wnt/Ca
2+
 pathway, the 
binding of Wnt to Fz activates hetromeric G-proteins and dishevelled, triggering protein kinase C 
(PKC) and calcium/calmodulin-dependent kinase 2 (CaMK2) activation, mediating the cell adhesion 
and motility. (C): In non-canonical or PCP pathway, the binding of Wnt ligand to Fz activates 
dishevelled, which subsequently activates the small GTPases, Rho and Rac, mediating cell movements 
and cytoskeleton changes.  
 
 
1.3.1 Wnt/β-Catenin Dependent Pathway 
The Wnt/-catenin dependent pathway is an ancient, conserved and one of the well 
described signaling cascade, which is triggered by the binding of the canonical Wnt to 
its receptor Fz and Lrp5/6, leading to degradation of the axin, adenomatous poliposis 
coli (APC), and glycogen synthase kinase3 (GSK3) complex, resulting in 
accumulation of -catenin in the cytosol. In the Wnt/β-catenin dependent pathway, -
catenin acts as a main transcriptional co-activator to trigger expression of target 
genes. In order to understand easily, this pathway can be described in an OFF 
(without Wnt) and an ON (with Wnt) model (Fig. 5). 
 
OFF Model 
In the absence of the Wnt ligand, β-catenin is phosphorylated in the positions of 
serine-33/37 and threonine-41 (Kimelman and Xu, 2006) by GSK3β-Axin-APC 
degradation complex through ubiquitin degradation mediated by β-transducin repeat 
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containing E3 ubiquitin protein ligase (β-TrCP), resulting in a low concentration of β-
catenin in the cytosol (Mac Donald et al., 2009). However, it is not totally understood 
yet how β-catenin is phosphorylated under the degradation complex. 
 
Figure 5. Wnt/-catenin dependent signaling pathway.  
(A): Off model. In the absence of Wnt, cytosolic -catenin is continuously phosphorylated by the -
catenin destruction complex, which consists of Axin, GSK3, APC, and CK1. The -TrCP recognizes 
the phosphorylated form of -catenin and degrade the target in an ubiquitin-dependent manner. (B): 
On model.  The binding of Wnt ligand to Fz and Lrp5/6 initiates degradation of GSK3-Axin-APC 
complex and phosphorylation of Lrp5/6, resulting in accumulation of cytosolic -catenin, which enters 
the nucleus and interacts with TCF/LEF to activate the Wnt target genes.  
 
 
ON Model  
The binding of the Wnt ligand to Fz and its co-receptor Lrp5/6 leads to internalization 
of Lrp6 phosphorylation through GSK3 or casein kinase-1 (CK1). The 
phosphorylated Lrp6 acts as a docking site for Axin, resulting in a stabilization of 
cytosolic -catenin against the GSK3 distraction complex in a dishevelled (Dvl) 
dependent manner. Accumulated cytosolic -catenin enters into the nucleus and binds 
to T-cell factor (TCF)/lymphoid enhancer factor (LEF), triggering transcription of the 
Wnt target genes, e.g., Axin2. 
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1.3.2 Wnt/β-Catenin Independent Pathway 
Wnt/β-catenin-independent pathway plays a key role for regulation of convergent 
extension movement during embryonic development (Sheldhal et al, 2003). This 
pathway doesn’t require an involvement of β-catenin and represents another diverse 
array of signaling pathways. Based on their specific receptor used, it is further divided 
into:  the Wnt/ Ca
2+
 dependent pathway and the planar cell polarity (PCP) pathway. 
 
Wnt/ Ca
2+
 Dependent Pathway 
The binding of the Wnt ligand to its Fz receptor leads to activation of heterotrimeric 
G-protein, followed by subsequent activation of phospholipase C (PLC), which 
cleaves phosphotidaylinositol-4,5-biphophate (PIP2) into diacylglycerol (DAG) and 
inositol-1,4,5-triphophate (IP3). Released IP3 from the membrane diffuses through 
cytosol and triggers Ca
2+
 release from the endoplasmic reticulum (ER), resulting in 
activation of DAG and protein kinase C (PKC). Released Ca
2+
 activates calcium-
calmodulin-dependent kinase II (CaMKII) and calcineurin (CaCN) (Kühl et al., 
2000). Phosphorylation of CaCN induces transport of the nuclear factor activated T-
cell (NFAT), resulting in the expression of target genes in different types of cells, 
including neuronal cells (Feske et al., 2003; Hogan et al., 2003).   
 
Planar Cell Polarity Pathway  
Wnt/PCP pathway is described first in the orientation of the facet for eyes and of hairs 
on wings in Drosophila. Studies in vertebrates show that PCP pathway controls cell 
movement and tissue polarity, inner ear development and neural tube closure (Seifert 
and Mlodzik, 2007). The binding of the Wnt ligand to its Fz and a co-receptor (ROR 
or RYK) activates Rho associated kinase (ROCK) and c-Jun terminal kinase (JNK) 
signalings (Sethi and Vidal-Puig, 2010). The binding of the Wnt ligand to Fz can also 
lead to activation of heterotrimeric G-proteins Ras homolog A (RHOA) and Ras-
related C3 botulinum toxin substrate-1 (RAC1) via Dvl. All these signals are involved 
in actin remodeling (Schlessinger et al., 2009). Interestingly, ROR2 mediated PCP 
pathway inhibits -catenin dependent signaling (Winkel et al., 2008), but RYK 
activates it (Berndt et al., 2011). More factors involved in the cooperation between 
Wnt/β-catenin-dependent and independent pathways have been also found out 
(Dworkin et al., 2011).  
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1.4 Proline-Rich Tyrosine Kinase 2  
Enzymes that transfer phosphate group from adenosine triphosphate (ATP) molecule 
to side chains of specific amino acids in target proteins are referred to as protein 
kinases, which are divided into phosphatases and tyrosine or serine/threonine kinases 
(Hunter, 1995). Based on the structure and location, protein tyrosine kinases (PTKs) 
are subdivided into the receptor PTK and non-receptor PTK (Neet and Hunter, 1996). 
Focal adhesion kinase (FAK) and proline-rich tyrosine kinse 2 (Pyk2) are two types 
of non-receptor PTKs. Pyk2 is also named as related adhesion focal tyrosine kinase 
(RAFTK), Ca
2+
 dependent tyrosine kinase (CADTK), protein tyrosine kinase 2 
(PTK2B) and cell adhesion kinase  (CAK). Pyk2 is expressed in hematopoietic 
cells, platelets, fibroblasts, and cells in the CNS (Stanzione et al., 2001). Pyk2 can be 
activated by an increased intracellular Ca
2+
 concentration, a change in osmolality, 
upon ultra violet irradiation and inflammatory cytokine stimulation, and various 
extracellular signals. Structurally, FAK and Pyk2 are very similar and Pyk2 contains a 
central catalytic domain flanked by N-terminal FERM domain and carboxy-terminal 
focal adhesion targeting regions (Fig. 7; Lipinski and Loftus, 2010). The N-terminal 
FERM domain mediates protein-protein and protein-membrane interactions. The 
tyrosine residue at 402 (Y
402
) position is a major auto-phosphorylation site of Pyk2 
and lies in FERM domain, which is regulated by Ca
2+
/calmodulin dependent catalytic 
activity. The phosphorylation of Pyk2 at Y
402 
and Y
881
 positions
 
facilitates the binding 
of the SH2 domain to Src and GRB2 (growth factor receptor bound 2), respectively 
(Dikic et al., 1996; Avraham et al., 2000). 
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Figure 6. The schematic structure of Pyk2 and the Pyk2 inhibitor PF-4618433.  
(A): The N-terminal FERM domain of Pyk2 mediates the protein-protein interactions. Phosphorylation 
of Pyk2 at tyrosine-402 (Y402) is a major auto-phosphorylation site regulated by Ca
2+
 and the 
phosphorylation at tyrosine-881 position facilitates the binding of Pyk2 to GRB2. At the carboxy 
terminus, Pyk2 contains a focal adhesion targeting (FAT) domain that binds to paxillin. (B): The 
chemical structure of Pyk2 inhibitor PF-4618433. 
 
 
Studies demonstrate that Pyk2 is involved in MAPK (mitogen activated 
protein kinase) signaling (Lipinski and Loftus, 2010). Upon stress stimulus, Pyk2 
activates JNK (c-Jun N-terminal kinase) signaling (Tokiwa et al., 1996; Yu et al., 
1996). Transient increase of intracellular Ca
2+
 can phosphorylate GSK3 at tyrosine-
216 position (Hartigan and Johanson, 1999) through Pyk2 (Hartigan et al., 2001). 
Pyk2 activation induces multiple intracellular cascades, resulting in reorganization of 
the cytoskeleton (Ivankovic-Dikic et al., 2000), vesicular transport regulation (Andrev 
et al., 2001), regulating neurite outgrowth (Ivankovic-Dikic et al., 2000) and neurite 
retraction (Sayas et al., 2006). Inhibition of Pyk2 induces osteogenic differentiation, 
leading to a novel approach in the treatment of osteoporosis (Buckbinder et al., 2007). 
The molecule of PF-562271 is used as a competitive inhibitor for both FAK and Pyk2 
and it produces an anti-tumor effect in xenograft tumor model after administration 
(Bagi et al., 2008). The molecule of PF-4618433 is used as specific inhibitor for Pyk2 
(Han et al., 2009). 
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1.5 Notch Signaling Pathway 
The Notch signaling pathway plays a key role during developmental embryos, 
especially in progenitor cell proliferation and specification (Cheng et al., 2010), 
angiogenesis, spermatogenesis, and neurogenesis (Hori et al., 2013). The Notch 
receptor is also recognized as an oncogenic protein, since more than 50% patients 
with T-cell lymphoblastic leukaemia have a mutant Notch1 and the Notch signaling is 
involved in carcinomas of the skin, the colon, the breast, and the lung as well as 
tumors in the CNS (Wilson A and Radtke F, 2006).  
The Notch receptor, comprising of an extracellular (ECN), a transmembrane 
(TMN) and an intracellular (ICN) subunit, is a single-pass transmembrane protein and 
binds to its ligands of the DSL (Delta, Serrate, Lag-2) transmembrane proteins (Fig. 
6). In mammals there are four Notch receptors, described as Notch1 (TAN1), Notch2, 
Notch3 and Notch4 (Int3), and five DSL ligands, indicated as Delta1, Delta3, Delta4, 
Jagged1 and Jagged2 (Bray, 2006).  
The binding of DSL to the epidermal growth factor repeats (EGFR) in the ECN 
subunit of the Notch receptor leads to subsequent cleavages of it through alpha-
secretase ADAM (a disintegrin and metalloprotease) protein and γ-secretase, resulting 
in the release of Notch intracellular domain (NICD), which translocates from the 
cytosol into the nucleus (Callahan and Egan, 2004) and forms a tri-protein complex 
with a DNA-bound protein CSL (suppressor of hairless lag-2, also known as RBPJ) 
and a transcriptional co-activator mastermind (Ong et al, 2006), activating the target 
genes. In the absence of NICD, this tri-protein complex is displaced by histone 
deacetylases (HDACs) and ubiquitous co-repressor proteins (Co-R) (Kopan et al., 
2009; Imayoshi et al., 2013). 
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Figure 7. Schematic representation of Notch signaling pathway.  
(A): The Notch receptor consists of an extracellular domain including EGF repeats, Lin12 notch 
repeats (LNR), a transmembrane domain (TMD) and an intracellular domain including a J-associated 
molecular domain (RAM), ankykin repeats and proline/serine/glutamic acid/threonine rich motifs. (B): 
Notch signaling is initiated by a binding of Notch ligand expressed on an adjacent cell, followed by an 
enzymatic cleavage and release of intracellular Notch (NICD), which translocates into the nucleus and 
binds to the CSL transcription repressor and converts it into activator form, resulting in the 
transcription of the target genes (Diagram from Cheng et al., 2010). 
 
 
The well-known target genes in the Notch signaling pathway are the Hairy 
enhancer of split (HES) and its related repressor (HERP, also known as HEY) 
(Stylianou et al., 2006), which are encoded by a family of basic helix-loop-helix- 
(bHLH) transcriptional factors. During embryonic development, knockdown of the 
bHLH repressor genes results in an increase of HES genes, including ES1, HES3 and 
HES5, and impairs NSC proliferation with premature neurogenesis and incomplete 
gliogenesis. In contrast, Math, Mash1 and neurogenin activate bHLH genes and 
drives neurogenesis. However, they also induce the expression of the Notch ligand 
Delta, which up-regulates HES1 and HES5 proteins to maintain cells in an 
undifferentiated state. In the developing CNS, a dynamic balance between these 
transcription factors is necessary to maintain cells in a differentiated or 
undifferentiated state. 
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1.6 ADAM Family 
The members of the ADAM family are transmembrane-anchored protease, 
characterized by cleaving the extracellular domain of membrane-bound proteins and 
receptors. In developmental embryos, ADAMs plays a key role in cell-cell and cell-
matrix interactions, cell adhesion as well as cell differentiation (Becherer and Blobel, 
2003). So far 35 members of the ADAM family are identified in humans and 
vertebrates. In the Notch signaling, the ADAM can cleave the extracellular 
proteolysis site of the Notch receptor, resulting in activation of the Notch target genes. 
Dysregulation of ADAMs can induce diseases, for example, over-expression of 
ADAMs, such as ADAM9, ADAM12, and ADAM17, is associated with the breast 
cancer, and ADAM15 and ADAM10 with the prostate cancer. Abnormal ectodomain 
shedding by ADAMs can also lead to various disease, e.g., Alzheimer’s disease 
(ADAM10), multiple-sclerosis (ADAM17), cardiovascular diseases (ADAM10 and 
ADAM17) (Weber and Saftig, 2012). Recently, a role of pharmaceutical inhibitors for 
ADAM17 in TNF- mediated rheumatoid arthritis has been reported (kawaguchi and 
Hearing, 2011). In in vitro system, ADAM17 affects glial/neuronal cell fate decision 
during differentiation of NPCs (Romero Grimaldi et al., 2011).  
 
1.7 Aim of the Study  
The Wnt signaling pathway plays vital role in the developing CNS. Previous studies 
from our institute have shown that Wnt3a is involved in hNPC differentiation by 
regulating Wnt/β-catenin pathway (Mazemondet et al., 2011), spontaneous Ca2+ 
(Morgan et al., 2013) and HES5 amount (Hübner et al., 2010; Mußmann et al., 2014). 
Interestingly, Pyk2 activates STAT3 in HeLa cells (Shi and Kehrl, 2004) and HES5 
regulates STAT3 activity in the differentiation of astrocytes in the CNS (Kamkura et 
al., 2004). Therefore, we hypothesized that Wnt3a may alternate the intracellular Ca
2+
 
concentration, resulting in activation of Wnt/Ca
2+
-pathway, which then activates the 
relative down-streams, e.g., CaMKII and Pyk2, and finally, affects neuronal 
differentiation (Fig. 8). Furthermore, since Pyk2 makes a co-immunoprecipitation 
together with GSK3-β, and regulates GSK3-β activity (Hartigan et al., 2001), we 
hypothesized that Pyk2 also interacts with Lrp6 and β-catenin, which contributes to 
the interaction between canonical and non-canonical Wnt signaling pathways (Fig. 8). 
Therefore, in the present study, 1) whether Wnt/Ca
2+
 pathway is involved in hNPC 
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differentiation; 2) whether the interaction between canonical and non-canonical Wnt 
signaling pathways in differentiating hNPCs is regulated by Wnt3a via Pyk2; and 3) 
whether the interaction between Wnt signaling and Notch signaling pathways is 
involved in hNPC differentiation, will be further investigated in order to understand 
how Wnt3a precisely regulates hNPC differentiation. 
 
 
Figure 8: Hypothetical model to show interaction between canonical and non-canonical pathways 
via Pyk2 and Wnt-Pyk2-Notch signaling pathways induced by Wnt3a in the differentiating 
hNPCs.  
(A): Interaction between the canonical and non-canonical pathways via Pyk2. Wnt3a can induce both 
canonical and non-canonical pathways: in the canonical pathway, Wnt3a activates Lrp6, GSK3β and 
β-catenin. The stabilized β-catenin (shown in the green back ground) translocates into the nucleus to 
activate the target gene expression; in the non-canonical pathway, Wnt3a induces an increase of 
cytosolic Ca
2+
 concentration, which can activate CaMKII and Pyk2. Pyk2 may interact with other 
molecules of Lrp6, GSK3β and β-catenin. (B): Interaction between the Wnt pathway and Notch 
pathway through Pyk2. The dotted arrows indicate the proposed interactions and the solid arrows 
represent the known pathway.  
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2 Materials and Methods 
2.1 Materails  
2.1.1 Cell Line 
 
The ReNcell VM-197 cell line (hereafter as VM cell) supplied by the ReNeuron 
(Guildford, UK) is obtained from the midbrain of a ten-week old human fetus and 
immortalized by v-myc. VM cells are able to differentiate into neurons, astrocytes and 
oligodendrocytes (Donato et al., 2007, Hübner et al., 2010; Morgan et al., 2012) by in 
vitro system. 
2.1.2 Cell Culture Media, Supplements, Buffers and Solutions 
 
Cell culture                Supplier (Composition) 
DMEM     Invitrogen 
DMEM-F12     Invitrogen 
Mouse laminin    Trevigen 
B27      Invitrogen 
EGF      Roche 
bFGF      Roche 
Heparin sodium salt    Sigma 
Pencillin/Streptomycin   Sigma 
Gentamycin     Invitrogen 
L-Glutamine     Gibco 
Poly-L-ornithine    Sigma 
Poly-D-ornithine    Sigma 
Trypsin/EDTA    Invitrogen 
Trypsin/Benzonase    25 U/ml of Benzonase in Trypsin/EDTA 
Trypsin-inhibitor    Sigma 
Benzonase     Merck 
Trypsin-inhibitor/Benzonase   1%HSA, 25U/ml Benzonase, 0.55mg/ml
      Trypsin inhibitor in DMEM/F12 
Human Serum Albumin   Grifols 
Normal Goat Serum (NGS)   Dako 
DMSO      Sigma 
Bovine Serum Albumin   Roth 
 
Supplements     Supplier(Composition) 
Recombinant Human Wnt3a   R & D Systems 
PF-4618433     Snkinase 
 
Buffers and Solutions   Supplier (Composition) 
5X Lysis buffer    Promega 
10x SDS Electrophoresis buffer 188mM Glycine+250mM Tris+3.5 mM 
SDS 
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SDS transfer buffer 39mM Glycine+48mM Tris+3.5mM 
SDS+20% ethanol 
10x TBS     20mM Tris-HCl+150mM NaCl (pH 7.6) 
TBST      TBS with 0.1% Tween-20 
Blocking Solution    TBS with 5% BSA (Roth)  
 
2.1.3 Antibodies 
 
Antibodies used for Western blot (WB), immunocytochemistry (ICC) and FACS 
analysis were listed as following.  
 
Primary Antibodies 
 
Target Type Company Application Dilution 
GAPDH Mouse IgG1 Abcam (ab8245) WB 1:10000 
GAPDH Rabbit IgG1 Santa Cruz (SC-
335) 
WB 1:1000 
GSK3 Mouse IgG1 BD (610201) WB 1: 3000 
p-GSK3β (Ser9) 
 
 
p-GSK3β (Tyr 
216) 
Rabbit 
polyclonal IgG 
 
Rabbit 
polyclonal IgG 
Cell Signaling 
(9336) 
 
Santa Cruz (SC-
9035) 
WB 
 
 
WB 
1:2000 
 
 
1:1500 
 
 
-catenin 
 
Mouse IgG1 
 
Santa Cruz (SC-
7963) 
 
WB 
 
1:1000 
 
 
p--catenin 
(Ser33/37/Thr41) 
Rabbit 
polyclonal IgG 
Cell Signaling 
(9561) 
WB 1:1000 
 
 
LRP6 Rabbit 
polyclonal IgG 
Cell Signaling 
(2560) 
WB 1:1000 
 
phospho-Lrp6 
(Ser-1490) 
Rabbit 
polyclonal IgG 
Cell Signaling 
(2568) 
WB 1:1000 
 
     
CaMKII Rabbit 
polyclonal IgG 
Santa Cruz (SC-
9035) 
WB 1:1000 
 
phospho-
CaMKII (T216) 
Mouse IgG1 Santa Cruz (SC-
32289) 
WB 1:250 
 
 
Pyk2 Mouse 
monoclonal 
Santa Cruz (SC-
100379) 
WB 1:200 
 
phospho-Pyk2-
(402) 
Rabbit 
polyclonal IgG 
Abcam (ab4800) WB 1:250 
 
 
ADAM10 Rabbit 
polyclonal IgG 
Millipore 
(AB19026) 
WB 1:1000 
     
Tuji-1 Mouse IgG1 Santa Cruz (SC- FACS,  1:100 
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51670) ICC 1:500 
 
Negative control Normal mouse 
IgG 
Santa Cruz (SC-
2025) 
FACS 1:100 
 
Negative control Normal rabbit 
IgG 
Santa Cruz (SC-
2027) 
FACS 1:100 
     
Secondary Antibodies 
 
Target Host Conjugate Company Application Dilution 
 
rabbit IgG goat Alexa Flour 
680 
Invitrogen 
(A-21076) 
WB 1:10000 
rabbit IgG goat IRDye 800 Rockland 
(61-131-
122) 
WB 1:10000 
mouse IgG goat Alexa Flour 
680 
Invitrogen 
(A-21057) 
WB 1:10000 
mouse IgG goat IRDye 800 Rockland 
(610-131-
003) 
WB 1:10000 
rabbit IgG goat Alexa Flour 
647 
Invitrogen 
(A-21245) 
FACS, ICC 1:1000 
mouse IgG goat Alexa Flour 
488 
Invitrogen 
(A-11029) 
FACS, ICC 1:1000 
 
2.1.4 Technical Equipment and Kits 
 
Technical Equipments 
    
Name                                      Type                                      Supplier 
Cell counter CASY Innovatis 
Incubator WTC Binder 
Sterile work bench Antares Sterile 
 
Microscopy                            Type                                      Supplier 
Cell culture microscope Eclipse TS100 Nikon 
Fluorescence microscope Biozero Keyence 
Fluorescence microscope Eclipse TS102 Nikon 
   
Electrophoresis                      Type                                      Supplier 
SDS-PAGE chamber Criterion Bio-Rad 
Semi-dry-transfer chamber Trans-Blot SD Bio-Rad 
Power-supplier PowerPacHC Bio-Rad 
 
Centrifuges Type Supplier 
Centriguge Z383K Hermle 
Centrifuge Z233MK-2 Hermle 
Centrifuge Universal 30 RF Hettich 
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Centrifuge Avanti J-25 Beckman Coulter 
 
Miscellaneous Type Supplier  
Vortexer MS1 IKA 
Spectrophotometer Ultraspec3100pro Amersham 
Shaker KM-2Akku Edmund Bühler 
Shaker K2-50 Noctuna 
Shaker Titramax-100 Heidolph 
Real-time PCR cycler LightCyclernano1.0 Roche 
Plate reader Magellan Tecan 
Pipets Reference Eppendorf 
pH meter  Mettler Toledo 
Nucleofactor NucleofectorII Amaxa 
FACS FACSCalibur Becton Dickenson 
Balance MCBA100 Sartorius 
Heatingblock Thermomixer Eppendorf 
 
Kits 
Name    Cat. Number   Supplier 
BCA Protein Assay Kit 23228    Pierce 
FastLane Cell cDNA Kit 215011   Qiagen 
 
2.1.5 Oligonucleotide Primers for Quantitative Real-Time PCR 
 
Gene Annealing Amplicon  Primer sequence 5’-3’ Reference 
  (°C)  length (bp)/  (forward and reverse) 
   Melting temp.(°C) 
 
hG6PD   55°C  191/88   F: atcgaccactacctgggcaa Hübner et   
R: ttctgcatcacgtcccgga al., 2010 
 
hHES5    55°C  232/90   F: tcagccccaaagagaaaaac  Chen et al., 
R: tagtcctggtgcaggctctt 2006 
  
hHES1    60°C 100/88   Property   Qiagen Cat 
          no: 
                     QT00039648 
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2.2   Methods 
2.2.1  Cultivation of Human Neuronal Progenitor Cells  
 
For cell proliferation, VM cells were placed in a T-75 flask coated with 6 ml laminin 
(1:100 with ice-cold DMEM F12 for minimum 1 h) at 37°C under the condition with 
5% CO2 and 20% O2. After 70-80% confluence in the proliferation media, cells were 
washed with 15 ml pre-warmed HBSS (37°C) and detached by adding 2.5 ml 
Trypsin/Benzonase, followed by 5 ml Trypsin-inhibitor/Benzonase solution for 
stopping reaction. Then cells were collected by centrifuged at room temperature for 
5 min at 1500xg and resuspended with 5 ml warm medium for cell counting. For cell 
differentiation, 15 ml media without growth factors was added to the washed cells for 
incubation at 37°C under the condition with 5% CO2 and 20% O2 and cells were 
collected at different time points as wanted. 
 
2.2.2 Cell Number Measurement and Seeding  
CASY cell counter (Innovatis, Reutlingen, Germany) was used to count the cell 
number. After 25 µl of cell suspension was added to 10 ml CASY ton, the cell 
number was measured with an appropriate program and the numbers of the cells 
seeded in different types of plates were shown in the Table 1. 
 
Table 1. The number of cells seeded in different types of plates. 
Cell line  Type of 
plate 
Surface area 
per well 
(cm
2
) 
Cell 
number/well 
Proliferation 
time 
VM cells  4-Well 2 50,000 48h 
VM cells  6-Well 25 250,000 48h 
VM cells  24-Well 2 50,000 48h 
 
 
 
2.2.3 Protein Analyses 
 
2.2.3.1   Preparation of Cell Lysates and Protein Measurement 
Cells were washed with 1x PBS and were harvested on ice with 1x Lysis buffer 
(Promega, USA), containing phosphatase and protease inhibitors cocktails (Roche) 
for 15 min on shaking. Then cell solution was centrifuged at 4°C for 15 min at 
15000x g and the supernatant was collected and stored at -80°C. Total protein 
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concentration was measured by bicinchoninic acid assay (BCA, Pierce, Rockford, IL, 
USA) according to manufacturer’s guidelines using a plate reader (Tecan GENios, 
USA). Samples diluted with 5x sample buffer (Thermoscientific, Rockford, USA) 
were boiled for 5 min at 95 °C for Western blotting. 
 
2.2.3.2   Western Blot Analysis 
Equal amount of proteins were loaded in a vertical Tris-HCl gel with 4-15 % 
acrylamide concentration gradient (Criterion Precast, Bio-Rad) and run in a Criterion 
Cell (Bio-Rad) at 100-200 V in ice-cold water bath for about 2 h. PeqGOLD marker 
IV (PEQLAB, Erlangen, Germany) was used as the protein marker. Then proteins 
within the gel were transferred to nitrocellulose membranes (Hybond-ECL, 
Amersham) by a semi-dry blotting system (Trans-BlotSD, Bio-Rad) at 0.10 A per 
membrane for 2 h. The membranes were soaked in the blocking solution (5 % BSA or 
5 % milk in TBST) for 2 h, followed by overnight incubation with primary antibodies 
at 4 °C on a shaker. Then membranes were washed for 5 min with TBST for 3 times 
and incubated in dark with suitable fluorescent secondary antibodies for 1.5 h. 
Thereafter, the membranes were washed 3 times for 5 min with TBST and air-dried in 
dark. Odyssey Infrared Imaging System (LI-COR Biosciences GmbH, Bad Homburg, 
Germany) was used to image and quantify the desired proteins. The membranes were 
scanned at a wavelength of 700 nm and 800nm for Alexa Fluor 680-labeled 
antibodies and IRDye 800CW-labeled antibodies, respectively. GAPDH was used as 
a loading control and the desired proteins were normalized to GAPDH for a relative 
expression level. Odyssey software version 1.4 was used to analyze the data. 
 
2.2.3.3   FACS Analysis 
Fluorescence-activated cell sorting (FACS) is used to analyze neurogenesis using 
neuronal marker β-tubulin in heterogeneous mixture of cell populations. After 
cultured in six-well plates were washed with HBSS, cells were subsequently treated 
with trypsin inhibitor/benzonase and trypsin/benzonase solutions. Then cells were 
fixed at room temperature in 1 % PFA in PBS for 20 min. After centrifugation at 
1500x g at 4 °C for 10 min, the pellet was suspended in 500 µl of FACS wash buffer 
and stored at 4°C. For cell staining, the cells were centrifuged for 5 min at 4 °C at 
2000x g. Wash buffer was removed and 25 µl of saponin buffer containing the 
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primary antibody were added to the pellet and incubated at room temperature on a 
shaker for 2 h. Cells added with normal mouse and normal rabbit IgG were used as 
negative controls. After 2 h cells were washed twice with 300 µl of saponin buffer 
and resuspended in 25 µl saponin buffer with appropriate secondary antibodies. 
Samples were incubated for 1 h at room temperature in dark with mild shaking. 
Finally cells were washed two times with 300 µl saponin buffer and centrifuged, 
followed by resuspended in 500 µl of FACS wash buffer and stored at 4°C in dark 
until the further analysis. Using FACS calibur (Becton Dickinson, San Jose, USA) in 
a combination with CellQuest Pro software, the samples (50,000 cells per sample) 
were counted under the same condition and the data were analyzed after aggregated 
cell and debris were filtered out.  
 
2.2.3.4   Immunocytochemistry 
Cells cultured on coverslips were fixed with 4 % PFA in PBS for 20 min at room 
temperature. After washed with PBS, the cells were blocked with 5% goat serum in 
PBS for 30 min and incubated overnight with primary antibody, containing 1% goat 
serum in PBS at 4 °C. On the next day, the cells were washed 3 times with PBS and 
incubated in dark with a secondary antibody for 1 h at room temperature. Finally, 
nuclear staining was performed with DAPI solution for 5 min. The coverslips were 
embedded carefully with mowiol, and stored at 4 °C in the dark until analysis. A 
control staining of the cells was performed with PBS solution instead of primary 
antibodies to check the background. Fluorescent images were generated using a 
fluorescent microscope (Bioxx-8000, Keyence, Germany). 
 Neurite length was measured in the images of immunocytochemistry using 
antibody against β-III tubulin - a specific neuronal marker - using the Keyence 
software according to the manufacture’s guidance. The Images (each area size with 
593 µm
2
) were randomly chosen for quantification and at least 5 images were used for 
one independent experiment. 
 
2.2.4 Intracellular Ca
2+
 Measurement 
Intracellular Ca
2+ 
was measured by using Ca
2+ 
sensitive fluorescent dye Fura-2/AM 
(Invitrogen, Germany). The binding of Ca
2+ 
to Fura-2/AM results in a change of the 
emission and excitation wave lengths from 340 nm to 380 nm and the ratio of this 
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shift was used to calculate the cytosolic Ca
2+ 
concentration (Grynkiewicz et al. 1985). 
The exact determination of intracellular Ca
2+
 concentration depends on the Kd value 
of the dye, which is affected by temperature, pH, viscosity and the presence of other 
divalent ions especially Mg
2+
. For Ca2+ measurement, cells growing on coverslips 
were incubated with Fura-2/AM with a final concentration of 5µM for 30 min at room 
temperature, and then washed three times with the extracellular solution, followed by 
a further incubation for 30 min to allow the binding of Ca
2+
 to Fura-2. The imaging 
was performed under the same perimeters using the image system of TillVision (v4.0, 
Till Photonics, Germany) with an illumination provider (Polychrome V, Till 
Photonics). The excitation wavelength can be shifted from Fura-2 with 340 nm to 
Ca
2+
-Fura2 binding with 380 nm, and the exposure time was naturally 15 
microseconds with adjusted depending on the signal intensity. Images were attained at 
1Hz over a period of 1000 seconds. Recordings were made from the somas of the 
cells of interest by manual chosen. Ratio-metric movies were created off-line and the 
background subtraction was done per frame based on a specific region of the image 
containing no cells. This experiment was supported with the help of Dr. Peter 
Morgan.  
 
2.2.5   Molecular Biological Methods 
 
2.2.5.1 cDNA Synthesis 
Fast Lane cDNA kit (Qiagen, USA) was used to generate cDNA, fallowing the 
manufacturer’s protocol. In brief, cells were grown in plates with 4 or 24 wells and 
washed with 200µl of FCW buffer. After incubation with 80µl of FCP buffer for 10 
min, genomic DNA was eliminated and cell lysates were collected for RNA synthesis. 
Template RNA was added to the reverse transcription master mix and cDNA 
synthesis was performed according to the manufacturer’s guide lines. The synthesised 
cDNA sample was stored at -20
°
C for the further usage.  
 
2.2.5.2 Quantitative Real-Time PCR (qRT-PCR) 
qRT-PCR was performed using the  LightCycler Nano 1.0 (Roche) instrument with 
FastStart Essential DNA Green Master Mix (Roche) according to the guidelines of the 
manufacture. Primer information can be found in the section 2.1.5 and the efficiency 
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of the primers were calculated by plotting Cq values vs cDNA amounts of the serial 
diluted positive control as human total brain cDNA (Clontech). 1µl of cDNA, which 
was generated using Fast Lane cDNA kit (Qiagen) was used as the template. In the 
experiment, all the samples were run as triplicates and the cycling parameters can be 
found in the Table 2. Delta-delta Ct method (Pfaffl et al., 2000) was used to calculate 
the relative changes of the amount of mRNA. Desired, interested mRNA amount was 
normalized to the house keeping gene G6PD (Glucose-6-phosphate-dehydrogenase) 
and the relative changes were calculated in compared to the control. 
  
Table 2. Cycling parameters used in quantitative real-time PCR 
Step Temparature (°C) Time 
Denaturation 95 10 min 
Denaturation 95 20 sec 
Annealing See 2.1.5 20 sec 
Extension 72 23 sec 
Melting curve 60-95  
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3 Results 
3.1 Wnt3a Stabilize β-Catenin Only at Early Time Points  
After cultured VM cells reached 80% confluence in the proliferation  differentiation 
of VM cells was performed by the withdrawal of growth factors from the proliferation 
media and accompanied by adding Wnt3a (100ng/ml) to the medium.  
 
 
Figure 9: Wnt3a does not stabilize β-catenin at certain time points during VM cell 
differentiation.  
Western blot analyses of phosphorylated Lrp6 at serine 1490 position (p-Lrp6) and phosphorylated β-
catenin at serine 33/37/Thr47 position (p-β-cat) in differentiating VM cells at defined time points under 
stimulation with Wnt3a (100ng/ml). (A): Western blot bands of p-Lrp6, p-β-catenin from cultured cell 
lysates treated with Wnt3a and HSA and harvested at 0.5h, 1h, 3h and 6h after differentiation. HSA 
serves as the control. (B): Quantified Western blot analyses by Odyssey Software for p-Lrp6 and p-β-
catenin. Values were normalized to the control and presented as mean ± SEM from three individual 
experiments. The control was set to 1, as indicated by black lines. Student’s T-Test was used: *p< 0.05, 
**p< 0.01, ***p< 0.01. 
 
 
Then the cells were harvested at the defined time points to investigate by 
Western blot analyses for target proteins, such as phosphorylated Lrp6 at Serine 1490 
position (hereafter as p-Lrp6) and phosphorylated β-catenin at Ser-33/37/Thr 41 
(hereafter as p-β-catenin). Results showed that under stimulation of Wnt3a, the 
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amount of p-Lrp6 in VM cells was increased in the defined time points from 0.5h 
onwards (Fig. 9A, B), confirming that Wnt3a can phosphorylate Lrp6 (Mazemondet 
et al., 2011). 
However, stabilization of β-catenin, revealed by the decrease of p-β-catenin, 
was only observed at time points of 0.5h and 1h, but not at 3h and 6h (Fig. 9A, C). 
Therefore, it gave rise to the question why β-catenin was not stabilized at 3h and 6h 
points even under stimulation of Wnt3a with a higher amount of p-Lrp6. 
3.2 Wnt3a Triggers Changes of Intracellular Ca2+  
Wnt3a can activate non-canonical pathways in some types of cells, e.g., articular 
chondrocytes (Nalesso et al., 2011), mesenchymal stem cells (Qu et al., 2013), and 
PC3 cells (Thrasivoulou et al., 2013). Previous study has shown that the spontaneous 
and transient Ca
2+
 signal was observed in VM cells (Morgan et al., 2013). Therefore, 
in the present study the effect of Wnt3a on intracellular Ca
2+
 concentration was 
investigated using Fura-2/AM-based method.  
The results showed that in the condition with the extracellular medium 
containing Ca
2+
 ion (2 mM), Ca
2+ 
transients were observed strongly in some cells 
treated with Wnt3a (Fig. 10B, D), but very weak in the cells treated with HSA, which 
serves as the control (Fig. 10A, C). Furthermore, when without Ca
2+
 ion in the 
medium, the Ca
2+
 transients were also observed under stimulation with Wnt3a, 
suggesting that Wnt3a can also trigger Ca
2+
 release from the intracellular organelles 
(Fig. 10E). This point was further identified by adding thapsigargin to medium, which 
discharges the Ca
2+
 from the intracellular organelles, especially endoplasmic 
reticulum (Thrasivoulou et al., 2013). When thapsigargin was added first into the 
medium and triggered Ca
2+
 release from the intracellular organelles, then the Ca
2+
 
transients triggered by Ca
2+
 release from the intracellular pools under stimulation with 
Wnt3a was deleted (Fig. 10F). Taken together, these results showed that Wnt3a can 
increase the cytosolic Ca
2+
 concentration by influx of Ca
2+
 from extracellular area and 
release from intracellular organelles, suggesting that Wnt3a may induce Wnt/Ca
2+
-
pathway in the differentiating VM cells.  
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Figure 10: Wnt3a increases intracellular calcium concentration by calcium influx from medium 
and release from intracellular organelles.  
(A-D): Changes of Ca
2+
 transients are observed in VM cells by Fura-2/AM-based fluorescent method, 
where blue color indicates the low level of cytosolic calcium and yellow/green color the high level. 
When the extracellular medium contains calcium ion (2 mM), Wnt3a strongly induces the Ca
2+
 
transients in cells indicated by yellow/green color (B) and peaks (D), but very weak in the control with 
HSA (A, C). The arrows indicate the time point to apply HSA and Wnt3a. (E, F): When the 
extracellular medium does not contain any calcium ion, the Ca
2+
 transients were observed in some 
Wnt3a treated cells in the absent with thapsigargin (E), but not in the first present with thapsigargin 
(F) in the medium. 
 
 
3.2.1 Wnt3a Regulates Calcium/Calmodulin Dependent Protein 
Kinase II  
An increase of cytosolic Ca
2+
 concentration can induce a release of a Ca
2+
-binding 
protein calmodulin (CaM), which subsequently binds to the calcium/calmodulin 
dependent protein kinase II (CaMKII), resulting in CaMKII activation via 
autophosphorylation at threonine-286 (T-286) position (Bossuyt and Bers, 2013). 
Therefore, CaMKII phosphorylation was further investigated under stimulation with 
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Wnt3a (100ng/ml) in differentiating VM cells. Western blot analyses showed that the 
amount of the total CaMKII were increased in all defined time points (Fig. 11A, B), 
while an increase of p-CaMKII only at 0.5h, but  a decrease at 1h and 3h time points 
when compared to the control (Fig. 11A, B), suggesting that Wnt3a increased amount 
of CaMKII via the increase of cytosolic Ca
2+
 concentration. 
 
 
Figure 11: Wnt3a regulates calmodulin dependent protein kinase II in differentiating VM cells. 
Western blot analyses of total CaMKII (t-CaMKII) and phosphorylated CaMKII at threonine 286 
position (p-CaMKII) in differentiating VM cells at defined time points under stimulation with Wnt3a 
(100ng/ml). (A): Western blot bands of t-CaMKII and p-CaMKII from cultured cell lysates as well as 
the control using HSA at 0.5h, 1h, and 3h after differentiation. (B): Quantified Western blot analyses 
by Odyssey Software for t-CaMKII and p-CaMKII. Values were normalized to the control and 
presented as mean ± SEM from three individual experiments. The control was set to 1, as indicated by 
the black line. Student’s T-Test was used: *p< 0.05, **p< 0.01, ***p< 0.01. 
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3.2.2 Wnt3a Triggers Phosphorylation of Proline-Rich Tyrosine 
Kinase 2 
Phosphorylation of Pyk2 at Tyr-402 (p-Pyk2), which is the major phosphorylation site 
for the initiation of Pyk2 kinase activity, is regulated by Ca
2+
 concentration (Sharma 
and Kinsey, 2013). Therefore, we continued to investigate whether Wnt3a activates 
Pyk2 phosphorylation. After cultured under stimulation with Wnt3a (100ng/ml), VM 
cells were harvested at defined points and Western blot analyses was performed.  
 
 
Figure 12:  Wnt3a triggers Pyk2 phosphorylation during VM cell differentiation. 
Western blot analyses of total Pyk2 (t-Pyk2) and phosphorylation of Pyk2 at tyrosine 402 position (p-
Pyk2) during VM cell differentiation at defined time points under stimulation with Wnt3a (100ng/ml). 
(A): Western blot bands of t-Pyk2 and p-Pyk2 from cultured cell lysates as well as the control using 
HSA at 0.5h, 1h, and 3h after differentiation. (B): Quantified Western blot analyses by Odyssey 
Software for t-Pyk2 and p-Pyk2. Values were normalized to the control and presented as mean ± SEM 
from three individual experiments. The control was set to 1, as indicated by the black line. Student’s T-
Test was used: *p< 0.05, **p< 0.01, ***p< 0.01. 
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Results showed that the total amount of Pyk2 (t-Pyk2) was not changed at 
different time points, but the amount of p-Pyk2 significantly increased at 0.5h and 1h 
when compared to the control, suggesting that Wnt3a triggers Pyk2 phosphorylation 
in the differentiating VM cells. 
3.3 Inhibition of Endogenous Pyk2 and Exogenous Overexpression 
of Pyk2  
Next step, a novel Pyk2 specific inhibitor PF-4618433 (hereafter as PF-461; Han, et 
al., 2009, Lipinski et al., 2010) was chosen for inhibition of endogenous Pyk2 in the 
experiments. In order to find out at which concentration PF-461 works efficiently on 
Pyk2 function in VM cells, different concentration of PF-461 was screened in the 
cultured cell system. Cell survival results by CASY assay showed that the viability of 
cultured cells at 6h under the stimulation with PF-461 at concentration of 0.5 µM was 
the highest (Fig. 13A, B). Furthermore, Western blot analyses showed that both p-
Pyk2 and t-Pyk2 were decreased at 0.5 and 3h under stimulation with PF-461 at 
concentration of 0.5 µM (Fig. 13C), suggesting that PF-461 specifically and 
efficiently inhibited Pyk2 in differentiating VM cells. Therefore, the concentration of 
0.5 µM PF-461 was selected as an optimal dose for the experiments for the inhibition 
of endogenous Pyk2.  
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Figure 13:  Effect of Pyk2 inhibitor PF-461 on Pyk2 in differentiating VM cells.  
(A): The cell viability was evaluated under stimulation with Pyk2 inhibitor PF-461 at different 
concentration as indicated in A as well as the control DMSO at 6h after cell differentiation using CASY 
assay. Relative percentages of the viability were calculated by normalizing the PF-461 treated cells to 
the control DMSO treated cells and presented as mean ± SEM from three individual experiments. The 
control was set to 1, as indicated by the black line. (B): Phase contrast images of differentiating cells 
treated with DMSO and PF-461 at 3h, respectively. Scale bar: 100 µm. (C): Western blot analyses of 
the decrease of p-Pyk2 and t-pPyk2 under stimulation with PF-461 (+), when compared to the control 
(-).  
 
 
 
In collaboration with the Institute for Experimental Gene Therapy und 
Tumour Research from University of Rostock, Pyk2 overexpression plasmid 
pWPXL+PTK2B was constructed (Fig. 14A) according the method described by 
others (Salmon and Trono, 2007; Alla et al., 2012) and stabilized Pyk2-
overexpressing VM cells was obtained. By Western blot, the amount of Pyk2 was 
strongly increased in the Pyk2-overexpression cells (Pyk2-o/e; Fig. 14C) when 
compared to the control (Fig. 14C), suggesting that the constructed stabilized Pyk2-
overexpressing cells can further used as exogenous overexpression of Pyk2 in the VM 
cells. 
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Figure 14: Pyk2-overexpressing plasmid map and Western blot analysis of Pyk2 amount in Pyk2-
stabilized expression VM cells.  
(A): Plasmid map of pWPXL+PTK2B with an insertion of Pyk2 (PTK2B) in the lentiviral vector 
pWPXL. (B): The image under red-fluorescence (VM-RFP) of the control stabilized RFP expressing 
VM cells (red) and the phase contrast image of the stabilized Pyk2-overexpressing cells (VM-Pyk2) at 
48 h in proliferating state. (C): Western blot analysis confirms that Pyk2 is strongly increased in the 
Pyk2-stabilized expression VM cells (Pyk2-o/e) when compared to the control. 
 
 
3.4 Effect of Pyk2 on Lrp6 Phosphorylation  
Phosphorylated Lrp6 plays an important role in triggering Wnt/β-catenin dependent 
pathway. GSK3β regulates phosphorylation of Lrp6 and β-catenin (Zeng et al., 2005) 
and proline directed kinases regulates Lrp6 phosphorylation (Niehrs and Shen, 2010). 
Pyk2 is a member of the proline rich tyrosine kinase family, and therefore, it is 
interesting to investigate whether Pyk2 plays a role in the regulation of Wnt/β-catenin 
dependent pathway.  
Therefore, in the present study, the effects of Pyk2 on Lrp6 phosphorylation 
were investigated using Pyk2-inhibitor PF-461 for Pyk2 down-regulation and 
stabilized Pyk2-overexpressing cells for Pyk2 exogenous overexpression (Pyk2 in 
Fig. 15C, D), respectively. After cells were treated in the different experimental 
groups with Wnt3a (100 ng/ml), PF-461 (0.5 µM), Pyk2-overexpression, and Wnt3a 
plus PF-461 or Pyk2-overexpression, the cultured VM cells were harvested at defined 
time points after differentiation. The results demonstrated that Wnt3a increased p-
Lrp6 significantly at the defined time points (Fig. 15A-D). However, PF-461 and 
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overexpression of Pyk2 had no effect on Lrp6 (Fig. 15A-D), suggesting that Pyk2 has 
no effect on Lrp6 phosphorylation. 
 
Figure 15: Effect of Pyk2 on Lrp6 phosphorylation in differentiating VM cells.  
VM cells were treated with Wnt3a (100 ng/ml), PF-461 (0.5 µM), and Wnt3a plus PF-461 or in Pyk2-
overexpression cells, respectively, and then harvested at 0.5h and 3h after differentiation. HSA and 
DMSO were used as controls for Wnt3a and PF-461, respectively. (A, B): Western blot bands of p-
Lrp6 (A) and quantified Western blot analyses by Odyssey Software for p-Lrp6 (B) in the control and 
treatment groups under stimulation with Wnt3a and/or PF-461 at 0.5h and 3h after differentiation. 
Values were normalized to the control and presented as mean ± SEM from three individual 
experiments. The control was set to 1, as indicated by the black line. Student’s-T-Test: *p< 0.05, **p< 
0.01, ***p< 0.01. (C, D): Western blot bands of p-Lrp6 (C) and quantified Western blot analyses by 
Odyssey Software for p-Lrp6 (D) in distinct control and treatment groups with Wnt3a and Pyk2-
overexpression cells (Pyk2) at 0.5h and 3h after differentiation. Values were normalized to the control 
and presented as mean ± SEM from three individual experiments. The control was set to 1, as indicated 
by the black line. Student’s T-Test was used: *p< 0.05, **p< 0.01, ***p< 0.01. 
 
 
3.5 Effect of Pyk2 on GSK3β Phosphorylation 
GSK3β phosphorylation is a key step in the Wnt/β-catenin dependent pathway. 
However, the mechanism of regulating GSK3β phosphorylation is not totally clear 
(Taelman et al., 2010). Pyk2 can regulate GSK3β function (Sayas et al., 2006) and 
therefore, the effect of Pyk2 on GSK3β phosphorylation was investigated in 
differentiating VM cells. In the present study, the effects of Pyk2 on GSK3β 
phosphorylation were investigated using Pyk2-inhibitor PF-461 for Pyk2 down-
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regulation and stabilized Pyk2-overexpressing cells for Pyk2 exogenous 
overexpression (Pyk2 in Fig. 16C-F), respectively. After the cells were treated in the 
different experimental groups with Wnt3a (100 ng/ml), PF-461 (0.5µM), Pyk2-
overexpression, and Wnt3a plus PF-461 or Pyk2-overexpression, the cultured VM 
cells were harvested at defined time points after differentiation.  
 
Figure 16: Figure 16: Effect of Pyk2 on GSK3β phosphorylation in differentiating VM cells.  
VM cells were treated with Wnt3a (100 ng/ml), PF-461 (0.5 µM), Wnt3a plus PF-461 or in Pyk2-
overexpression cells, respectively, and then harvested at 0.5h and 3h after differentiation. HSA and 
DMSO were used as controls for Wnt3a and PF-461, respectively. (A, B): Western blot bands of p-
GSK3βSer9 (A) and quantified Western blot analyses by Odyssey Software for p-GSK3βSer9 (B) in the 
control and treatment groups under stimulation with Wnt3a and/or PF-461 at 0.5h and 3h after 
differentiation. Values were normalized to the control and presented as mean ± SEM from three 
individual experiments. The control was set to 1, as indicated by the black line. Student’s-T-Test: *p< 
0.05, **p< 0.01, ***p< 0.01. (C-F): Western blot bands of p-GSK3βSer9 (C) and p-GSK3βT216 (E), 
quantified Western blot analyses by Odyssey Software for p-GSK3βSer9 (D) and p-GSK3βT216 (F) in the 
control and treatment groups with Wnt3a and/or in Pyk2-overexpression cells at 0.5h and 3h after 
differentiation. Values were normalized to the control and presented as mean ± SEM from three 
individual experiments. The control was set to 1, as indicated by the black line. Student’s T-Test was 
used: *p< 0.05, **p< 0.01, ***p< 0.01. 
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Experimental results demonstrated that at both 0.5h and 3h after cell differentiation, 
PF-641 alone significantly decreased the amount of phosphorylated GSK3β at serine 
9 (p-GSK3βser9; Fig. 16A, B), indicating an increase of GSK3β activity (Cross et al., 
1995). Furthermore, the amount of p-GSK3βser9 in both Wnt3a and Wnt3a plus PF-
461 groups was significant different (Fig. 16B), suggesting that PF-461 affected p-
GSK3βser9 even under stimulation with Wnt3a.  
 
For exogenous overexpression of Pyk2, p-GSK3βser9 amount was not changed in the 
defined time points after cell differentiation (Fig. 16C, D). However, the amount of 
phosphorylated GSK3β at tyrosine 216 (p-GSK3βT216), was decreased at 0.5 h and 3 h 
after differentiation (Fig. 16E, F), suggesting that Pyk2 can decrease GSK3β activity, 
as indicated by a decrease of p-GSK3βT216 diminishes GSK3β activity (Hughes et al., 
1993). Taken together, these data suggest that Pyk2 can decrease GSK3β activity, 
possibly playing a role in the interaction between the canonical and non-canonical 
pathways. 
 
3.6 Effect of Pyk2 on β-Catenin Phosphorylation 
The inhibition of Pyk2 can reduce β-catenin expression in bone-marrow stromal cells 
(BMSCs; Zhang et al., 2014). Therefore, the effect of Pyk2 on the expression of β-
catenin was also evaluated after inhibition and overexpression of Pyk2 in 
differentiating VM cells.  
 
In the present study, the effects of Pyk2 on β-catenin phosphorylation were 
investigated using Pyk2-inhibitor PF-461 for Pyk2 down-regulation and Pyk2-
overexpressing cells for Pyk2 exogenous overexpression (Pyk2 in Fig. 17C, D), 
respectively. After the cells were treated in the different experimental groups with 
Wnt3a (100 ng/ml), PF-461 (0.5µM), Pyk2-overexpression, and Wnt3a plus PF-461 
or Pyk2-overexpression, the cultured VM cells were harvested at defined 0.5 h and 3h 
time points after differentiation. 
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Figure 17: Effect of Pyk2 on β-catenin phosphorylation in differentiating VM cells.  
VM cells were treated with Wnt3a (100 ng/ml), PF-461 (0.5 µM), Wnt3a plus PF-461 or in Pyk2-
overexpression cells, respectively, and then harvested at 0.5h and 3h after differentiation. HSA and 
DMSO were used as controls for Wnt3a and PF-461, respectively. (A, B): Western blot bands of p-β-
catenin (p-β-cat) and quantified Western blot analyses by Odyssey Software for p-β-cat (B) in the 
control and treatment groups under stimulation with Wnt3a and/or PF-461 at 0.5h and 3h after 
differentiation. Values were normalized to the control and presented as mean ± SEM from three 
individual experiments. The control was set to 1, as indicated by the black line. Student’s-T-Test: *p< 
0.05, **p< 0.01, ***p< 0.01. (C, D): Western blot bands of p-GSK3β (C) and quantified Western blot 
analyses by Odyssey Software for p-GSK3β (D) in the control and treatment groups with Wnt3a and/or 
in Pyk2-overexpression cells at 0.5h and 3h after differentiation. Values were normalized to the control 
and presented as mean ± SEM from three individual experiments. The control was set to 1, as indicated 
by the black line. Student’s T-Test was used: *p< 0.05, **p< 0.01, ***p< 0.01. 
 
 
 
Results showed that Wnt3a decreased the phosphorylated β-catenin at Ser 
33/37/Thr41 (p-β-catenin; unstabilization form) at 0.5h, but not at 3h (Fig. 17A, B). 
PF-461 alone increased p-β-catenin at 0.5 and 3h after differentiation, and PF-461 
together Wnt3a also significantly increased p-β-catenin at 0.5h when compared to 
Wnt3a alone (Fig. 17A, B), suggesting that PF-461 may affect Wnt3a mediated p-β-
catenin change. At 3h after differentiation, Wnt3a increased p-β-catenin, and PF-461 
together with Wnt3a also increased p-β-catenin. However, the difference of p-β-
catenin amount between the group of PF-461 together with Wnt3a and Wnt3a alone 
was not significant (Fig. 17A, B). Furthermore, the exogenous overexpression of 
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Pyk2 alone had no effect on p-β-catenin amount at 0.5h, but decreased it at 3h (Fig. 
17C, D). However, the combination of Wnt3a and Pyk2 overexpression failed to 
stabilize β-catenin at 3h after differentiation (Fig. 17C, D). These data indicated that 
PF-461 may interfere β-catenin stabilization at defined time point, and exogenous 
overexpression of Pyk2 stabilized β-catenin at 3h, although the effect of Pyk2 on p-β-
catenin may not involve in Wnt3a mediated p-β-catenin regulation in the 
differentiating VM cells.   
     
3.7 Influence of Pyk2 on Notch Signaling Pathway 
Previous report from our institute demonstrated that HES5 gene is a key regulator in 
Wnt3a-induced VM cell differentiation (Mußmann et al., 2014) and ADAM10 also 
regulates Notch signalling pathway. As Wnt3a induces Pyk2 expression in VM cells, 
therefore, it is interesting to investigate whether Wnt3a can affect Notch signaling via 
Pyk2.  
 
3.7.1 Effect of Pyk2 on HES1 and HES5  
In order to investigate whether the expression of Notch target factors - HES1 and 
HES5 - were affected by Pyk2, the effects of Pyk2 on Notch target factors, HES1 and 
HES5 gene were investigated using Pyk2-inhibitor PF-461 for Pyk2 down-regulation 
and Pyk2-overexpressing cells for Pyk2 exogenous overexpression (Pyk2 in Fig. 18B, 
D), respectively.  After the VM cells were treated in different groups with Wnt3a (100 
ng/ml), PF-461 (0.5µM), and Wnt3a plus PF-461 or in Pyk2-overexpression cells, 
respectively, the cultured VM cells were harvested at 3h and 6h time points after 
differentiation. Real-time PCR results showed that Wnt3a increased the mRNA 
amount of HES1 (Fig. 18A), but decreased HES5 (Fig. 18C) at 3h and 6h after 
differentiation, as demonstrated by previous published report; PF-461 increased the 
amount of HES1 at 3h and 6h (Fig. 18A), and of HES5 at 6h (Fig. 18C); A 
combination of PF-461 and Wnt3a also increased mRNA level of HES1 (Fig. 18A), 
but decreased HES5 (Fig. 18C). However, the differences of HES5 between the 
combination group and Wnt3a group were not significant (Fig. 18C). Furthermore, 
the exogenous overexpression of Pyk2 induced HES1 mRNA expression at the 
defined time points (Fig. 18B), and HES5 at 6h except of at 3h with a decrease (Fig. 
18D). A combination of Wnt3a and Pyk2 transfection also increased mRNA level of 
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HES1 (Fig. 18B), but decreased HES5 (Fig. 18D) at the defined time points except of 
0.5h after differentiation. Moreover, exogenous overexpression of Pyk2 had no effects 
on HES1 mRNA level, but Pyk2 significantly decreased HES5, when compared to the 
control (Fig. 18E), suggesting Pyk2 also affects HES5 mRNA level at 3 days after 
differentiation. 
 
 
Figure 18: Effects of Pyk2 on HES1 and HES5 in VM cells revealed by real-time PCR analysis.  
VM cells were treated with Wnt3a (100 ng/ml), PF-461 (0.5 µM), Wnt3a plus PF-461 or in Pyk2-
overexpression cells, respectively. Then the cells were harvested at 0.5h, 3h, 6h, and 3 days after 
differentiation. HSA and DMSO were used as controls for Wnt3a and PF-461, respectively. Quantified 
mRNA levels of HES1 (A, B, E) and HES5 (C, D, E) in the control and treatment groups under 
stimulation with PF-461 (A, C) and exogenous Pyk2 overexpression (Pyk2; B, D, E). Values were 
normalized to the control and presented as mean ± SEM from three individual experiments. The 
control was set to 1, as indicated by the black lines. Student’s-T-Test: *p< 0.05, **p< 0.01, ***p< 
0.01.  
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3.7.2  Effect of Pyk2 on ADAM10  
Previous report showed that Wnt3a regulates ADAM10 expression in mouse primary 
cortical neurons (Wan et al., 2012) and the down-regulation of ADAM10 affects 
HES5 protein level by in vivo and in vitro studies (Yan et al., 2014). Wnt3a can 
regulate Pyk2 expression and Pyk2 affects HES5, therefore, it is also interesting to 
investigate whether Pyk2 can regulate ADAM10. In the present, Pyk2-overexpressing 
cells were used for Pyk2 exogenous overexpression (Pyk2 in Fig. 19). After the cells 
were treated in the different experimental groups with Wnt3a (100 ng/ml) in the 
control and Pyk2-overexpression cells, the cultured VM cells were harvested at 0.5h 
and 3h time points after differentiation. Results showed that Wnt3a can reduce 
premature ADAM10 (110 kDa) at both 0.5h and 3h; the exogenous overexpression of 
Pyk2 also decreased the amount of ADAM10 at 0.5h and 3h (Fig. 19A, B), and a 
combination of Pyk2 transfection and Wnt3a also decreased ADAM10 protein 
expression at the defined time points (Fig. 19). 
 
                         
Figure 19: Effect of Pyk2 on ADAM10 expression.   
VM cells were treated with Wnt3a (100 ng/ml) in the control and Pyk2-overexpression cells, 
respectively, and then harvested at 0.5h and 3h after differentiation. HSA and pWPXL+RFP 
transfected cells were used as controls for Wnt3a and Pyk2-overexpression, respectively. Western blot 
bonds (A) and quantified protein level (B) of premature ADAM10 in the control and treatment groups 
as indicated. Values were normalized to the control and presented as mean ± SEM from three 
individual experiments. The control was set to 1, as indicated by the black line. Student’s T-Test was 
used: *p< 0.05, **p< 0.01, ***p< 0.01.  
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3.8 Effect of Pyk2 on Neurite Outgrowth  
Previous studies have shown that Wnt3a induces neuronal genesis (Hübner et al., 
2010) via HES5 (Mußmann et al., 2014) molecule in the differentiating VM cells. 
FAK and Pyk2 interact with integrin and growth factor receptors, increasing neurite 
outgrowth in PC 12 and SH-SY5Y cells (Ivankovic-Dikic et al., 2000). Therefore, it is 
interesting to study whether Pyk2 play a role in neurogenesis and neurite outgrowth in 
differentiation VM cells. After the cells were treated in the different experimental 
groups with Wnt3a (100 ng/ml) in the control and Pyk2-overexpression cells, the 
cultured VM cells were harvested for FACS and immunocytochemistry using 
antibody against β-III tubulin, a specific marker for neurons, at 3 days after 
differentiation. The results showed that as previous identified, Wnt3a induced 
neurogenesis in VM cells, but Pyk2 did not by FACS analyses (Fig. 20A). However, 
both Wnt3a and Pyk2 increased neurite length in the differentiating VM cells, as 
revealed by immunocytochemistry (Fig. 20B-F).  
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Figure 20:Effects of Pyk2 on neurogenesis and neurite length.   
VM cells were treated with Wnt3a (100 ng/ml) in the control and Pyk2-overexpression cells, 
respectively, and then harvested at 3 days after differentiation. HSA and pWPXL+RFP transfected 
cells were used as controls for Wnt3a and Pyk2-overexpression, respectively. FACS analysis and 
quantification of neurite length were measured in the control and treatment groups as indicated. 
Values were normalized to the control and presented as mean ± SEM from three individual 
experiments. The control was set to 1, as indicated by the black line. Student’s T-Test was used: *p< 
0.05, **p< 0.01, ***p< 0.01.  
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4 Discussion 
Wnt signaling plays an important role in tissue formation and neurogenesis during 
embryonic development. Previous studies from our laboratory have shown that Wnt 
signaling pathway is involved in the processes of hNPC differentiation (Hübner et al., 
2010), including regulating spontaneous Ca
2+
 (Morgan et al., 2012) and HES5 amount 
(Mußmann et al., 2014). However, mechanisms involving in the regulation of hNPC 
differentiation in VM cells are still not totally clear. Recently, Wnt3a has been found 
to induce both canonical and non-canonical pathways in some types of cells (Nalesso 
et al., 2011). Therefore, in the current research, I study whether Wnt3a induces a non-
canonical pathway and how the interaction between Wnt canonical and non-canonical 
pathways affects expression of their target genes and proteins, and neuronal 
differentiation. 
4.1 Activation of Lrp6 and Stabilization of β-catenin 
It was shown that Wnt3a induces phosphorylation of Lrp6 at serine 1490 position and 
stabilization of β-catenin. Several studies have explained about how Wnt signalling 
affects β-catenin, e.g., 1) phosphorylated Lrp6 induced by Wnt3a directly inhibits 
GSk3β activity (Piao et al., 2008); 2) Wnt3a induces disruption of GSK3β-Axin 
interaction and causes a separation of GSK3β from β-catenin, resulting in β-catenin 
stabilization (Liu et al., 2005); 3) under Wnt3a stimulation, GSK3β triggers 
dephosphorylation of Axin at Ser497/500 and causes dissociation of Axin with Lrp6 
and β-catenin, resulting in the inhibition of β-catenin phosphorylation (Kim et al., 
2013); 4) an increase of cytosolic Ca2
+
 concentration and activation of PKCα 
mediated by Wnt5a result in degradation of β-catenin (Gwak J et al., 2006). 
The previous study in our institute has shown that Wnt3a increases Lrp6 
phosphorylation during VM cell differentiation (Mazemondet et al., 2011), but the 
relationship between activation of Lrp6 and stabilization of β-catenin has not been 
focused. In the current study, we found that Wnt3a induces phosphorylation of Lrp6 
at serine 1490 position and subsequently stabilizes β-catenin at 0.5h and 1h after VM 
cell differentiation, but not at 3h and 6h points (Fig. 9). This phenomenon is also 
revealed in RKO cells (Hernandez et al., 2012) and L-cells (Kim et al., 2013). 
Recently, several studies have further reported the novel mechanisms about Lrp6 
phosphorylation and β-catenin stabilization. GSK3β bounds to Axin, interacts with 
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cytosolic region of Lrp6, which is phosphorylated at serine/threonine residues in 
PPPS/TP motifs (Wantae et al., 2013).  
Wnt3a induces formation of phosphotidylinositol 4,5-biphosphate (PIP2), 
which in turn activates Lrp6 (Pan et al., 2008). Furthermore, phospholipase C (PLC) 
cleaves PIP2 into inositol-1,4,5-triphosphate (IP3) and diacylglycerol (DAG), and IP3 
releasing from the membrane triggers an increase of Ca
2+
 in the cytosol (Kühl, 2004). 
Therefore, we asked whether Wnt3a also activates Wnt/Ca
2+
 pathway in the 
differentiating VM cells and how these processes are related to the degradation of β-
catenin at the defined time points under a high level of phosphorylated Lrp6 after 
differentiation. Indeed, Wnt3a can induce an increase of cytosolic Ca
2+
 concentration 
by a Ca
2+
 influx from the extracellular medium and release from the intracellular 
organelles, resulting in an increase of activated phosphorylated CaMKII and Pyk2 
(Fig. 10). Niehers and co-workers found that, an unknown proline directed kinase 
mediates the phosphorylation of Lrp6 at Serine 1490 and Threonine 1479 positions 
(Niehrs and Shen, 2010). Since Pyk2 is a proline-rich tyrosine kinase, we 
hypothesised that Pyk2 can induces Lrp6 phosphorylation and mediates the 
stabilization of β-catenin. However, overexpression of Pyk2 failed to induce 
phosphorylation of Lrp6 in VM cells (Fig. 15 C, D), but induces stabilization of β-
catenin (Figs. 17, 21). Therefore, the reason why the β-catenin is degraded underlying 
the high level of phosphorylated Lrp6 is still unclear and should be further 
investigated. 
4.2 Wnt3a Triggers Wnt/Ca2+ Pathway  
Free cytosolic Ca
2+ 
plays a role as the second messenger to trigger distinct pathways 
and normal regulation of free cytosolic Ca
2+
 concentration is important for 
physiological processes in cells. Wnt3a can elicit intracellular Ca
2+
 in rat embryonic 
hippocampal neurons (Avila et al., 2010) and in human articular chondrocytes 
(Nalesso et al., 2011). In the present study, the data showed that Wnt3a increases 
cytosolic Ca
2+
 concentration mediated by the influx of Ca
2+
 from the extracellular 
medium and also the release from the intracellular organelles, as revealed with the 
help of thapsigargin (Fig. 10), which can abolish a release of Ca
2+
 from endoplasmic 
reticulum under treatment with Wnt5a, Wnt9B, Wnt10B in PC3 cells (Thrasivoulou et 
al., 2013). Furthermore, Wnt3a can increase activated phosphorylated CaMKII in VM 
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cells (Fig. 11), possibly mediated by the increase of cytosolic Ca
2+
 concentration, 
suggesting that Wnt3a can trigger Wnt/Ca
2+
 -pathway in the differentiating VM cells. 
An increase of cytosolic Ca
2+
 concentration activates CaMKII protein in a 
two-step process. The binding of Ca
2+
 to calmodulin enhances phosphorylation of the 
kinase domain of CaMKII at threonine 286 position, resulting in the formation of an 
active form of CaMKII with an autonomous activity, although the detailed 
mechanism is still not clear (Hoffman et al., 2011). Wnt3a activates Ca
2+
/CaMKII 
non-canonical pathway together with β-catenin dependent canonical pathway, 
regulating distinct transcriptional targets in differentiation of human articular 
chondrocytes (Nalesso et al., 2011). Wnt5a can activate CaMKII to promote ventral 
cell fates in Xenopus embryos (Kühl et al., 2000) and increase intracellular Ca
2+
 levels 
in rat hippocampal neurons (Varella-Nallar et al., 2010), resulting in an increase of 
nitric oxide (NO) generation lasting for only 1h and modulating N-methyl-D-aspartate 
(NMDA) receptors (Munoz et al., 2014). Subsequently, NMDA receptors can 
promote Ca
2+
 influx and regulates p-CaMKII (T286) formation in some type of cells, 
e.g., rat cortical neurons (Zhou, et al., 2012). Whether Wnt3a affects NO and NMDA 
activation and results in activation of CAMKII in VM cells is still unknown.  
4.3 Wnt3a Activates Pyk2  
Activation of G-protein couple receptors and hydrolysis of PIP2 lead to 
phosphorylation of Pyk2 in PC12 cells (Lev et al., 1995) and PIP2 is also involved in 
phosphorylation of Lrp6 at Serine1490 position induced by Wnt3a (Pan et al., 2008). 
In the present study, Wnt3a increases the amount of p-Lrp6 protein (Fig.9) and 
cytosolic Ca
2+
 concentration in VM cells (Fig.10). Furthermore, Wnt3a also induces 
phosphorylation of Pyk2 at Tyrosine 402 position (p-Pyk2
(402)
) in VM cells (Fig. 12). 
To the best of our knowledge, this is the first report describing that Wnt3a can induce 
phosphorylation and activation of Pyk2 in cells.  
Regulation of Pyk2 phosphorylation in cells is complicated and has been 
described in some types of cells. For example, transient increase of intracellular Ca
2+
 
concentration induces activation of Pyk2 in rat epithelial cells (Yu et al., 1996). In 
vitro experiment has shown that a few micro-molar Ca
2+
 concentration is enough to 
induce p-Pyk2
(402)
 formation and cytosolic Ca
2+
 influx from extracellular medium is 
the main source of Ca
2+
 to activate Pyk2 (Kinsey, 2013). p-Pyk2
(402)
 is the first and 
major phosphorylated form response to Ca
2+
 transient (Wu, et al., 2006). Reduction of 
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NMDA receptors mediated by decrease of Ca
2+
 influx leads to a decrease of Pyk2 
activity in rat hippocampus after the happening of cerebral ischemia (Liu et al., 2003; 
Ma et al., 2004). EGF triggers IP3 generation, resulting in transient Ca
2+
, which 
induces Pyk2 activation in fibroblasts (Xie et al., 2008). Furthermore, TRPM2 
(Transient receptor potential cation channel member 2) channel mediated Ca
2+ 
influx 
activates Pyk2 in human monocytes (Yamamoto et al., 2008).  
Pyk2 is mainly distributed in the CNS and some other tissues and plays a very 
important role for keeping normal physiological function of cells. For example, 
activation of Pyk2 induced by transient Ca
2+
 is essential for fertilization of oocytes 
from the rat (Meng et al., 2006) and the zebrafish (Sharma et al., 2013). Pyk2 is 
essential for regulating osteoprogenitor cell development and bone formation, and 
Pyk2-knockout mice demonstrate an increased osteogenesis, causing high bone mass. 
Similar results have also been observed in rates treated with the Pyk2 inhibitor PF-
431396 (Buckinder et al., 2007) and in human mesenchymal stem cells treated with 
PF-461 (Han et al., 2009), offering a basic strategy for osteoporosis treatment. 
In the current study, PF-461 can successfully inhibit Pyk2 activity and 
decrease Pyk2 amount in VM cells (Fig. 13), suggesting that PF-461 is a potential 
candidate for inhibition of Pyk2. Furthermore, structural analyses revealed that PF-
461 is more specific and selective to inhibit Pyk2, whereas PF-431396 inhibits both 
Pyk2 and FAK (Han, 2009). Taken together, in differentiating VM cells Wnt3a 
triggers Wnt/Ca
2+
-pathway, increases cytosolic Ca
2+
 concentration (Fig. 10) and 
activates CaMKII (Fig. 11), and also induces phosphorylation and activation of Pyk2 
(Fig. 12), which can be inhibited by its antagonist PF-461 (Fig. 13). Based on the 
function of Pyk2, it is important to study whether Pyk2 can regulate the components 
of Wnt/β-catenin pathway during VM cell differentiation (see below in detail).  
 
4.4 Effect of Pyk2 on Components in Wnt/β-Catenin Singaling 
Pathway 
Protein tyrosine kinases and the Wnt signalling pathway play very important roles 
that regulate various developmental processes and there is an inter-connection 
between both cell signals. For example, non-receptor tyrosine kinase Pyk2 has a 
cross-talk with the components of Wnt/β-catenin pathway - GSK3β and β-catenin. In 
the present study, Pyk2 had no effect on p-Lrp6 (Fig. 15), but decreased GSK3β 
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activity (Fig. 16) and stabilized β-catenin (Fig. 17). Taken together, these results 
suggest that Pyk2 is involved in Wnt/Ca
2+
-pathway, and interacts with Wnt/β-catenin 
dependent pathway, in which Pyk2 decreases GSK3β activity and stabilizes β-catenin 
(Fig. 21).         
In multiple myeloma, stabilization of β-catenin is achieved by Pyk2 
overexpression, resulting in transcription of c-Myc and cyclin D1 (Zhang et al., 
2014). In mammalian cells, intracellular release of Ca
2+
 causes trafficking of β-
catenin into the nucleus (Thrasivoulou et al., 2013) and inhibition of Pyk2 increases 
the degradation of β-catenin (Zhang et al., 2014), suggesting that Pyk2 plays a role in 
the stabilization of β-catenin. Indeed our findings also revealed that inhibition of Pyk2 
by PF-461 destabilizes β-catenin, but overexpression of Pyk2 stabilizes β-catenin 
(Fig. 17), suggesting the important role of Pyk2 in regulation of Wnt/β-catenin 
pathway in hNPCs.  
The outcome of Wnt signal transduction in cells is decided by different 
factors, such as phosphorylation of Dvl (Sen, 2005; Gao and Chen, 2010) and the 
ability of Wnt ligand to form a complex with the upstream of Dvl - Fz receptors and 
co-receptor (Lrp6, Ror1/2; Grumolato et al., 2010). Growth factor receptor bound 
protein 2 (Grb2), a downstream molecule of Dvl2, can bind to Dvl2, as revealed by 
immunoprecipitation and Grb2-knockdown in HEK293 cells, in which it inhibits the 
Wnt3a-mediated β-catenin signalling (Crampton et al., 2009). On the other hand, p-
Pyk2
(402)
 facilitates the binding of Pyk2 to Grb2 (Blaukat et al., 1999), regulating 
Wnt/β-catenin pathway through Dvl2, Rac1, Jnk and c-jun (Crampton et al., 2009). 
These findings support our results that Pyk2 can interact with the components of 
Wnt/β-catenin dependent pathway (Figs. 16, 17).  
Although it is still a preliminary step in integration of cell singling cascade, 
deep focus might answer a lot of unresolved questions about how Wnt signaling 
works. The Wnt ligand induces intracellular Ca
2+
 increase and leads to stabilization of 
β-catenin (Avila et al., 2010; Thrasivoulou et al., 2013). The trafficking of β-catenin 
into the nucleus mediated by Pyk2 destroys VE-cadherin function of the cell-cell 
adhesion in vascular endothelial cells (Van Buul et al., 2005). Transient increase of 
intracellular Ca
2+
 increases GSK3β activity, promoting tau-protein phosphorylation in 
SH-SY5Y cells (Hartigan J A et al., 1999). All these data strongly support the 
concept, which was recognized in the current study, that Pyk2 activation induces by 
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an increase of cytosolic Ca
2+
 via Wnt3a stimulation plays an important role in the 
regulation of β-catenin stabilization in hNPCs. 
 
4.5 Effect of Pyk2 on Notch Singaling Pathway 
In Notch signaling pathway, the interaction between a ligand in one cell to the 
receptor in another cell triggers proteolytic cleavages of Notch receptor subsequently 
by either ADAM10 or ADAM17 and then by γ-secretase, resulting in a release of the 
intracellular fragment, which interacts with the nuclear factors to regulate the target 
gene expression, including Hes1, Hes5, Hey1, and Hey2 (Takebe et al., 2015). 
Previous studies from our institute have shown that Wnt3a promotes hNPCs 
differentiation, possibly mediated by Hes5 molecule (Mußmann et al., 2014). Down-
regulation of ADAM10 also decreases HES5 protein expression by both in vivo and 
in vitro systems (Yan et al., 2014). Furthermore, deletion of Wnt/β-catenin signaling 
inhibits ADAM10 upregulation in mouse cortical neurons (Wan et al., 2012). FAK 
protein also regulates activity of Notch signaling.  
Interestingly, overexpression of Pyk2 decreases ADAM10 protein expression 
in the VM cells (Fig. 19). A strong reduction of Notch target genes including HES5 
has been found in ADAM10-knockout mice (Zhuang et al., 2015). Down-regulation 
of ADAM10 strongly decreases HES5 expression in chicken spinal cord, resulting in 
precociously neuronal differentiation in the spinal cord and hNPCs (Yan et al., 2014). 
Therefore, Pyk2 triggered by the increase of cytosolic Ca
2+
 concentration mediated by 
Wnt3a can also affect Notch signalling by affecting ADAM10 and HES5 expression, 
resulting in an increase of neurogenesis and neurite outgrowth (Figs. 18-21).    
 
4.6 Effect of Pyk2 on Neurogenesis and Neurite Outgrowth 
Over expression of Wnt3a induces neurogenesis in mice hippocampal stem and 
progenitor cells (Lie et al., 2005). Wnt3a can induce neurogenesis in hNPCs through 
β-catenin independent pathway (Hübner et al., 2010). Overexpression of Pyk2 
decreases HES5 expression (Fig. 18D, E) in VM cells and induces neurite outgrowth 
(Fig. 20). Increasing neurite outgrowth in PC12 and SH-SY5Y cells has been 
observed under the condition with autophosphorylation of Pyk2, induced by growth 
factors and integrin signaling and and the inhibition of Pyk2/FAK blocks neurite 
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outgrowth (Ivankovic-Dikic et al., 2000). Interestingly, overexpression of Pyk2 
reduces the HES5 expression (Fig. 18D, E) in differentiating VM cells, supporting the 
concept of the involvement of Pyk2 in neurogenesis. Pyk2 and GSK3β are co-
immunoprecipitated in various cells (Hartigan et al., 2001). Inhibition of Pyk2 by 
tryphostin A9 and GSK3β by SB216763 partially inhibit neurite retraction in B103-
LPA1 cells (Sayas et al., 2006), suggesting that an involvement of Wnt-Pyk2 signaling 
in the differentiation of neurons. Although further studies are necessary to confirm the 
existence of Wnt-Pyk2 signaling in VM cells, the preliminary data from the present 
study support our hypothesis, i.e., Pyk2 induced by Wnt3a can mediate neurogenesis 
in VM cells. 
 
4.7 Integration of Wnt singaling and Notch Singaling via Pyk2 
Different signalling pathways, such as Wnt signaling, Notch signaling, and hedgehog 
signalling, cooperate with each other in embryogenesis and organism development. 
The cross-talk between the signaling pathways has been always paid attention by 
scientists to find out more key molecules for invention of new drugs, which are used 
in treatment for various diseases (Takebe et al., 2015).  
Although β-catenin and Ca2+ play a key role in different canonical and non-
canonical Wnt pathways, respectively, it is still not clearly understand how Wnt 
signalling is regulated. The current study identified that Pyk2 can decrease GSK3β 
and stabilize β-catenin and also decrease ADAM10 and HES5 expression, further 
extending a connection between Wnt signaling and Notch singaling via Pyk2 in 
differentiating hNPCs.  
Furthermore, Pyk2 can bind to STAT3, activating STAT3 activity and 
forming a positive-feedback loop between them (Verma et al., 2015). The binding of 
HES protein to STAT3 induces a cross-talk between the Notch and STAT pathways 
(Kamakura et al., 2004). The current results together with our previous data 
(Mußmann et al., 2014; Yan et al., 2014) demonstrate that decreased ADAM10 and 
HES5 by Wnt3a and Pyk2 during hNPCs differentiation make a connection between 
Wnt and Notch signaling pathways through Pyk2.  
Taken together, Pyk2 is involved in both Wnt signalling and Notch signalling 
and integrate both signalling pathways, suggesting an important role of Pyk2 in hNPC 
differentiation (Fig. 21).  
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Figure 21. Simplified model to show interaction between canonical and non-canonical pathways 
via Pyk2 and Wnt-Pyk2-Notch signaling pathways induced by Wnt3a in the differentiating NPC.  
Wnt3a increases cytosolic Ca
2+
 concentration, which can activate CaMKII and Pyk2. Subsequently, 
Pyk2 decreases GSK3β activity and stabilizes β-catenin, but not Lrp6, suggesting a crosstalk between 
Wnt/β-catenin and Wnt/Ca2+-pathways. Furthermore, Pyk2 decreases ADAM10 and HES5, and 
promote neurite outgrowth, suggesting that Pyk2 also involves in Notch signaling.  
 
4.8 Outlook 
The present data show that Wnt3a increases cytosolic calcium concentration by 
increasing calcium influx from extracellular space and calcium release from the 
intracellular organelles and induces activation of CaMKII and Pyk2, suggesting that 
Wnt3a can trigger Wnt/Ca
2+
 dependent pathway during hNPC differentiated. 
Activation of Pyk2 can decrease GSK3β activity and stabilizes β-catenin, suggesting 
an interaction between canonical and non-canonical Wnt signaling pathways during 
differentiation of hNPCs. Furthermore, overexpression of Pyk2 decreases the HES5 
mRNA amount and ADAM10 protein in the differentiating hNPCs, suggesting an 
involvement of Pyk2 in the Notch signaling pathway. Finally, Pyk2 overexpression 
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promotes neuronal differentiation and increases neurite length, suggesting a role of 
Wnt and Pyk2 in neurogenesis. 
Although the data shown in this study is very interesting, still some questions 
should be further investigated. For example, why is β-catenin degraded underlying a 
high level of p-Lrp6 at 3h and 6h after differentiation of hNPC under Wnt3a 
stimulation? Answer this question may give more detail to discover how other factors 
are involved in β-catenin regulation, and how they work together with Wnt3a to 
regulate β-catenin function, and what is the key role of Lrp6 in Wnt/β-catenin 
dependent pathway. Furthermore, Wnt3a at a low concentration induces the Wnt/β-
catenin dependent pathway, but at a high concentration triggers the Wnt/Ca
2+
 
dependent pathway, modulating precisely articular chondrocyte phenotype (Nalesso et 
al., 2011). In this study, Wnt3a can trigger Wnt/Ca
2+
 dependent pathway, therefore, it 
is interested to find out whether during hNPC differentiation, Wnt3a induces Wnt/β-
catenin and Wnt/Ca
2+
 dependent pathways is also in a dose-dependent manner, and 
which specific Wnt receptor mediates this different Wnt signaling pathways.   
Moreover, Pyk2 is involved in both Wnt and Notch signaling pathways, and it is also 
interested to study how Pyk2 regulates these two pathways and induces the interaction 
between them.  
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5 Summary 
 
HumanNPCs (hNPCs) are the suitable cell source for stem cell-based replacement of 
lost neurons in translation medicine for neurodegenerative disease and the benefit of 
cellular therapy is dependent on cell survival and differentiation after transplantation.  
In the present study, effects of Wnt3a on the differentiation of hNPC were 
studied using VM cell line as a cell model. The results showed that Wnt3a induces 
phosphorylation of Lrp6 and stabilization of β-catenin at early 0.5h and 1h, but not 3h 
and 6h after differentiation, suggesting other molecular mechanisms also regulate β-
catenin stabilization. Furthermore, Wnt3a increases transient cytosolic Ca
2+
 
concentration by triggering Ca
2+
 influx from the medium and Ca
2+
 release from the 
cellular organelles, as indicated by thapsigargin experiment. Furthermore, Wnt3a 
increases Ca
2+
 target genes CaMKII and Pyk2 in the differentiating VM cells. Pyk2 is 
a member of non-receptor PTKs and plays an important role in regulating cellular 
signaling pathways. Therefore, effects of Pyk2 were further investigated after 
endogenous Pyk2 inhibited by PF-461 or exogenous overexpression in stable Pyk2-
overexpressing VM cells. The results demonstrated that Pyk2 has no effect on Lrp6 
phosphorylation, but decreases GSK3β activity and stabilizes β-catenin, suggesting 
there is an intercross between Wnt/β-catenin and Wnt/Ca2+-pathway via Pyk2. 
Moreover, Pyk2 increases Notch targeting gene HES1, but decreases HES5 as well as 
ADAM10, suggesting Pyk2 is involved in Notch signaling during VM cell 
differentiation. Finally, Pyk2 increases neurite outgrowth at 3 days after VM 
differentiation.    
Wnt3a induces neurogenesis and neurite outgrowth via downregulation of 
HES5 mediated by Pyk2 was found out in the present study and Pyk2 is involved in 
not only Wnt signaling pathway, but also Notch signaling pathway, suggesting a 
crosstalk between Wnt signaling and Notch signaling via Pyk2. 
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7 Abbreviations 
AD  Alzheimer disease 
ADAM A disintegrin and metalloprotease 
ADSC  Adipose derived stem cell 
AKos  Albrecht Kossel Institute for Neuroregeneration 
APC  Adenomatous poliposis coli 
ATP  Adenosine triphosphate 
BCA  Bicinchoninic acid assay 
bFGF  Basic fibroblast growth factors 
bHLH  Basic helix-loop-helix 
BSA   Bovine serum albumin 
CaCN  Calcineurin 
CADTK Calcium dependent tyrosine kinase 
CAKβ  Cell adhesion kinase β 
CaM  Calmodulin 
CaMKII Calcium/calmodulin-dependent kinase II 
cDNA  Complementary DNA 
mRNA  Messenger RNA 
CK1  Casein kinase-1 
CNS  Central nervous system 
CSL  Suppressor of hairless lag-2, also named as CBF-1 
Ct  Cycle threshold 
DAG  Diacylglycerol 
DMEM Dulbecco’s modified eagle medium 
DNA  Deoxyribonucleic acid 
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Abreviations  
  
DSL  Delta Serrate Lag-2 
Dvl  Dishvelled 
ECN  Extracellular 
EDTA  Ethylene diamine tetra acetic acid 
EGF  Epidermal growth factor 
EGFR  Epidermal growth factor repeats 
ER  Endoplasmic reticulum 
ESC  Embryonic stem cell 
FACS  Fluorescence-activated cell sorting  
FAK  Focal adhesion kinases 
FERM  F for 4.1 protein, E for ezrin, R for radixin and M for moesin 
Fz  Frizzled 
G6PD  Glucose-6-phosphate dehydrogenase 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
GRB2  Growth factor receptor bound-2 
GSK3β Glycogen synthase kinase 3β 
h  Hour 
HBSS  Hank’s balanced salt solution 
HDAC  Histone deacetylase 
HERP  HES related repressor 
HES  Hairy enhancer of split 
hESC  Human embryonic stem cell 
hNPC  Human neural progenitor cell 
HSA  Human serum albumin 
ICC  Immunocytochemistry 
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Abreviations  
  
ICN  Intracellular 
iPS  Induced pluripotent stem cell 
JNK  c-Jun terminal kinase 
LEF  Lymphoid enhancer factor  
LNR  Lin12 Notch repeats 
Lrp5/6  Low density receptor related protein 
MAML Mastermind-like protein 
MAPK  Mitogen activated protein kinase  
MS  Multiple sclerosis 
NFAT  Nuclear factor activated T-cell 
NICD  Notch intracellular domain 
NMDA N-methyl-D-aspartate 
NPC  Neural progenitor cell 
PBS  Phosphate buffer saline 
PCP  Planar cell polarity 
PCR  Polymerase chain reaction 
PFA  Paraformaldihyde 
PIP2  Phosphotidylinositol-4,5-biphosphate 
PLC  Phospholipase C 
PTK2β  Protein tyrosine kinase 2β 
PTKs  Protein tyrosine kinases 
Pyk2  Proline-rich tyrosine kinase 2 (also named as PTK2β) 
q-RT-PCR Quantitative real-time PCR 
RAC1  Ras-related C3 botulinum toxin substrate-1 
RAFTAK Related adhesion focal tyrosine kinase 
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Abreviations  
  
RBPJ  Recombining binding protein suppressor of hairless 
RHOA  Ras homolog gene A 
RNA  Ribonucleic Acid 
ROCK  Rho associated kinase 
STAT3 Signal transducer and activator of transcription 3 
TCF  T-cell factor 
THAP  Thapsigargin 
TMD  Transmembrane domain 
TMN  Transmembrane 
WB  Western blot 
β-Trcp  β-transducin repeat containing E3 ubiquitin protein ligase 
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